Papers

5

Total Citations

149

H-Index

4

About

R. Bryan Bell is a leading head and neck surgical oncologist whose research centers on de-intensifying treatment for HPV-related oropharyngeal cancer through minimally invasive surgical approaches. His most impactful contribution is the landmark ECOG-ACRIN E3311 trial, which demonstrated that patients with p16+ oropharynx cancer undergoing transoral robotic surgery can safely receive reduced-dose adjuvant radiation (50 Gy instead of 60 Gy) without compromising two-year progression-free survival. This practice-changing study, cited over 100 times, has helped spare thousands of patients from the long-term toxicities of high-dose chemoradiation. Bell also pioneered the development of surgeon credentialing and quality assurance protocols for transoral robotic surgery, ensuring consistent outcomes across multicenter trials. His textbook "Oral, Head and Neck Oncology and Reconstructive Surgery" serves as a comprehensive reference for the field. With over 150 peer-reviewed publications and numerous national trial leadership roles, Bell has fundamentally reshaped the standard of care for HPV-positive oropharynx cancer, establishing transoral surgery as a cornerstone of treatment de-escalation strategies.

Research Focus

Key Achievements

4
H-Index
5
Papers
149
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
100 citations · 2020
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Providence Portland Medical Center, Oregon Health & Science University

Top Papers

  1. 1
  2. 2
    Oral, Head and Neck Oncology and Reconstructive Surgery
    24 citations · 2017
  3. 3
    Robotic Surgery
    12 citations · 2012
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago